Consensus on: Screening and therapy of coronary heart disease in diabetic patients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 10, 2011, Pages 757-764

  Rivellese, A A ^a   Piatti, P M ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cardiovascular risk factors; Coronary heart disease; Diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART MUSCLE REVASCULARIZATION; HUMAN; ITALY; RISK FACTOR; SHORT SURVEY;

ANTIHYPERTENSIVE AGENTS; CORONARY DISEASE; DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; ITALY; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS;

EID: 80053050833     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.07.005     Document Type: Short Survey

References (25)

1. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332:73-78.
2. Bruno G., De Micheli A., Frontoni S., Monge L. Standard Italiani per la Cura del Diabete Mellito 2009-2010. Torino (Italy) Infomedica 2010, for AMD and SID.
3. Wackers F.J.T. Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J Nucl Cardiol 2006, 13:609-615.
4. Rajagopalan N., Miller T.D., Hodge D.O., Frye R.L., Gibbons R.J. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005, 45:43-49. [Infomedica Ed].
5. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report National Cholesterol Education Program National Heart, Lung, and Blood Institute National Institutes of Health NIH Publication No. 02-5215 September 2002.
6. Bax J.J., Young L.H., Frye R.L., Bonow R.O., Steinberg H.O., Barrett E.J. ADA screening for coronary artery disease in patients with diabetes. Diabetes Care 2007, 30:2729-2736.
7. Aronow W.S., Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women <62 years of age. Am J Cardiol 1994, 74:64-65.
8. A randomised, blinded. Trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996, 348:1329-1339. CAPRIE steering Committee.
9. A report of the American College of Cardiology Foundation Appropriateness criteria Task Force, Society for cardiovascular angiography and interventions, Society of Thoracic Surgeons, American association for Thoracic Surgery, American heart association, and the American Society of Nuclear Cardiology. Circulation 2009, 119:1330-1352. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization.
10. Bacci S., Villella M., Villella A., Langialonga T., Grilli M., Rauseo A., et al. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002, 147:649-654.
11. Gerber T.C., Carr J.J., Arai A.E., Dixon R.L., Ferrari V.A., Gomes A.S., et al. Ionizing radiation in cardiac imaging A Science advisory from the american heart association committee on cardiac imaging of the council on clinical cardiology and committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention. Circulation 2009, 119:1056-1965.
12. Boden E.W., O' Rourke R.A., Teo K.K., Hartigon P.M., Moron D.J., Kostuk W.J., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516.
13. Frye R.L., August P., Brooks M.M., Hardison R.M., Kalsey S.F., MacGregor J.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515. BARI 2D Study Group.
14. Banning A.P., Westaby S., Morice M.-C., Kappetein A.P., Mohr F.W., Berti S., et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010, 55:1067-1075.
15. Mulukutla S.R., Vlachos H.A., Marroquin O.C., Selzer F., Holper E.M., Abbott J.D., et al. Impact of drug-eluting stents among insulin-treated diabetic patients A report from the NHLBI dynamic registry. JACC Cardiovasc Interv 2008, 1:139-147.
16. Bertrand M.E., Rupprecht H.J., Urban P., Gershliak A.H. CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000, 102:624-629.
17. Bhatt D.L., Bertrand M.E., Berger P.B., L'Acher P.L., Maesse I., Moses J.K., et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002, 39:9-14.
18. Roffi M., Eberli F.R. Diabetes and acute coronary syndromes. Best Pract Res Clin Endocrinol Metab 2009, 23:305-316.
19. Bhatt D.L., Marso S.P., Hirsch A.T., Risyleb P.A., Hacke N., Topol E.J. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002, 90:625-628.
20. Flaherty J.D., Charles J., Davidson C.J. Diabetes and coronary revascularization. JAMA 2005, 293:1501-1508.
21. Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007, 357:2001-2015.
22. Wiviott S.D., Braunwald E., Angiolillo D.J., Meisel S., Dalby A.J., Verheugt F.W., et al. TRITON-TIMI 38 Investigators. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 2008 Oct 14, 118(16):1626-1636. Epub 2008 Aug 31.
23. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Tcheng J.E., Neumann F.J., et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005 Apr 13, 293(14):1759-1765.
24. Garzon P., Eisenberg M.J. Functional testing for the detection of restenosis after percutaneous transluminal coronary angioplasty: a meta-analysis. Can J Cardiol 2001, 17:41-48.
25. Dori G., Denekamp Y., Fishman S., Bitterman H. Exercise stress testing, myocardial perfusion imaging and stress echocardiography for detecting restenosis after successful percutaneous transluminal coronary angioplasty: a review of performance. J Intern Med 2003, 253:253-262.